Onyx Pharmaceuticals, Inc. (ONXX) Reports Stronger-Than-Expected Q4 Results
Tweet Send to a FriendGet Alerts ONXX Hot Sheet
Price: $93.03 +0.13%
Revenue Growth %: +102.1%
Financial Fact:
Total operating expenses: 173.97M
Today's EPS Names:
SFL, RL, PERY, More
Revenue Growth %: +102.1%
Financial Fact:
Total operating expenses: 173.97M
Today's EPS Names:
SFL, RL, PERY, More
Trade ONXX Now!
Onyx Pharmaceuticals, Inc. (NASDAQ: ONXX) reported Q4 EPS of $1.50, $0.07 better than the analyst estimate of $1.43. Revenue for the quarter came in at $237 million versus the consensus estimate of $213.24 million.
For earnings history and earnings-related data on Onyx Pharmaceuticals, Inc. (ONXX) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For earnings history and earnings-related data on Onyx Pharmaceuticals, Inc. (ONXX) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Hewlett-Packard Company (HPQ) Tops Q2 EPS by 6c as Sales Slide 10%
- Brean Capital Raises Onyx (ONXX) Price Target to $115
- Onyx Pharmaceuticals Announces Data Presentations at the 18th Congress of the European Hematology Association
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
